Why it was recalled
Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
Product description
Testosterone/Anastrozole 60 mg/1 mg pellets packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.
Lot numbers, UPCs & expiration codes
Lot#: 20171130@64, BUD 05/29/2018.
Where it was sold
NV only
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0671-2018
- Classification
- Class II
- Status
- Terminated
- Recall initiated
- Mar 22, 2018
- FDA report date
- Apr 25, 2018
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Partell Specialty Pharmacy
Original FDA data
Every field from FDA enforcement report D-0671-2018, exactly as published.
Show all FDA fields
- City
- Las Vegas
- State
- NV
- Status
- Terminated
- Country
- United States
- Event ID
- 79619
- Address
- 5835 S Eastern Ave Ste 101
- Code information
- Lot#: 20171130@64, BUD 05/29/2018.
- Postal code
- 89119-3031
- Report date
- Apr 25, 2018
- Product type
- Drugs
- Recall number
- D-0671-2018
- Classification
- Class II
- Recalling firm
- Partell Specialty Pharmacy
- Termination date
- Jan 15, 2019
- Reason for recall
- Lack of Assurance Sterility: Firm is recalling various drug products due to a non-approved method of sterilization.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Testosterone/Anastrozole 60 mg/1 mg pellets packaged in amber vial, Rx only, Partell Specialty Pharmacy, 5835 S. Eastern Ave. #101, Las Vegas, NV 89119 (702) 791-3800.
- Distribution pattern
- NV only
- Recall initiation date
- Mar 22, 2018
- Initial firm notification
- Letter
- Center classification date
- Apr 17, 2018